The role of lipoxin A4 in exercise-induced bronchoconstriction in asthma

Journal of Asthma

Volumn 45, Issue 2, 2008, Pages 161-164

  Tahan, Fulya ^a   Saraymen, Recep ^a   Gumus, Hakan ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Asthma; Bronchoconstriction; Exercise; Lipoxin A4

Indexed keywords

IMMUNOGLOBULIN E; LIPOXIN A;

ADOLESCENT; ARTICLE; BLOOD LEVEL; BRONCHOSPASM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL COUNT; EXERCISE INDUCED ASTHMA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN TISSUE; MALE; PATHOGENESIS; SKIN TEST; STATISTICAL ANALYSIS;

ADOLESCENT; ASTHMA; ASTHMA, EXERCISE-INDUCED; BRONCHOCONSTRICTION; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXERCISE TEST; FEMALE; HUMANS; LIPOXINS; MALE;

EID: 40949087770     PISSN: 02770903     EISSN: 15324303     Source Type: Journal    
DOI: 10.1080/02770900701847068     Document Type: Article

References (31)

1. Busse WW, Lemanske RF, Jr. Asthma. N Engl J Med 2001; 344:350-362.
2. Sterk PJ, Fabbri LM, Quanjer PH, et al. Airway responsiveness. Standardized challenge testing with pharmacological, physical, and sensitizing stimuli in adults. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993; 16:53-83.
3. Lotvall J, Inman M, O'Byrne P. Measurement of airway hyperresponsiveness: new considerations. Thorax 1998; 53:419-424.
4. Van Schoor J, Joos GF, Pauwels RA. Indirect bronchial hyperresponsiveness in asthma: mechanisms, pharmacology, and implications for clinical research. Eur Respir J 2000; 16:514-533.
5. Anderson SD, Daviskas E. The mechanism of exercise-induced asthma is. J Allergy Clin Immunol 2000; 106:453-459.
6. Joos GF. Bronchial hyperresponsiveness: too complex to be useful? Curr Opin Pharmacol 2003; 3:233-238.
7. Eggleston PA, Kagey-Sobotka A, Lichtenstein LM. A comparison of the osmotic activation of basophils and human lung mast cells. Am Rev Respir Dis 1987; 135:1043-1048.
8. Serhan C, Hamberg M, Samuelsson B. Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leulocytes. Proc Natl Acad Sci U. S. A. 1984; 81:5335-5339.
9. Serhan CN. Lipoxins: biosynthesis and evidence for their involvement in respiratory disease. In: Robinson C, ed. Lipid Mediators in Allergic Diseases of the Respiratory Tract. Boca Raton: CRC Press, 1994, pp. 65-78.
10. Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN. Lipid mediator class swiching during acute inflammation: signals in resolution. Nat Immunol 2001; 2:612-619.
11. Banderia-Melo C. Cyclooxygenase-2-derived prostaglandin E2 and lipoxin A4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: relationship with concurrent eosinophilia. J Immunol 2000; 164:1029-1036.
12. Vachier I, Chanez P, Bonnans C, Godard P, Bousquet J, Chavis C. Endogenous antiinflammatory mediators from arachidonate in human neutrophils. Biochem Biophys Res Commun 2002; 290:219-224.
13. Serhan CN. Lipoxins and novel aspirin-trigered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeuti opportunity? Prostaglandins 1997; 53:107-137.
14. Banderia-Melo C, Boza PT, Diaz BL, Cordeiro RSB, Jose PJ, Martins MA, Serhan CN. Cutting edge: lipoxin A4 and aspirin-triggered 15-epi-LXA4 block allergen-induced eosinophil trafficing. J Immunol 2000; 164:226767-226771.
15. Levy BD, De Sanctis GT, Devchand PR, Kim E, Ackerman K, Schmidt BA. Multipronged inhibition of airway hyperresponsiveness and inflammation by lipoxin A4. Nat Med 2002; 8:1018-1023.
16. Li N, Wallen NH, Hjemdahl P. Evidence for prothrombotic effects of exercise and limited protection by aspirin. Circulation 1999; 100:1374-1379.
17. Ostrowski K, Rohde T, Asp S, Schjerling P, Pedersen BK. Chemokines are elevated in plasma after strenuous exercise in humans. Eur J Appl Physiol 2001; 84:244-245.
18. Pedersen BK, Steensberg A, Fischer C, Keller C, Ostrowski K, Schjerling P. Exercise and cytokines with paticular focus on muscle-derived IL-6. Exer Immunol Rev 2001; 536:18-31.
19. Todd MK, Goldfarb AH, Boyer BT. Effect of exercise intensity on 6-keto-PGF1 alpha, TXB2, and 6-keto-PGF1 alpha/TXB2 ratios. Thromb Res 1992; 65:487-493.
20. Gangemi S, Luciotti G, D'Urbano E, Mallamace A, Santoro D, Bellinghieri G, Davi G, Romano M. Physical exercise increases urinary excretion of lipoxin A4 and related compounds. J Appl Physiol 2003; 94:2237-2240.
21. Global Initiative for Asthma. Global strategy for asthma management and prevention. National Institutes of Health. National Heart Lung and Blood Institute. Revised, 2002.
22. Cropp GJ. The exercise bronchoprovocation test: standardization of procedures and evaluation of response. J Allergy Clin Immunol 1979;64:627-633.
23. Crapo RO, Casaburi R, Coates AL, et al. Guidelines for methacholine and exercise challenge testing - 1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000; 161:309-329.
24. Joos GF, O'Connor B, Anderson SD, et al. Indirect airway challenges. Eur Respir J 2003; 21:1050-1068.
25. Colgan SP, Serhan CN, Parkos CA, Delp-Archer C, Madara JL. Lipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers. J Clin Invest 1993; 92:75-82.
26. Christie PE, Spur BW, Lee TH. The effects of lipoxin A4 on airway responses in asthmatic subjects. Am Rev Resp Dis 1992; 145:1281-1284.
27. Leff AR. Role of leukotrienes in bronchial hyperresponsiveness and cellular responses in airways. Am J Respir Crit Care Med 2000; 161:125-132.
28. Clish CB. Local and systemic delivery of a stable aspirin-trigered lipoxin prevents neutrophil recruitment in vivo. Proc Natl Acad Sci U.S.A. 1999; 96:8247-8252.
29. Godson C. Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte derived macrophages. J Immunol 2000; 164:1663-1667.
30. Brezinski DA, Nestro RW, Serhan CN. Angipplasty triggers intracoronary leukotrienes and lipoxin A4: impact of aspirin therapy. Circulation 1992; 86:56-63.
31. Serhan CN, Fiore S, Brezinski DA, Lynch S. Lipoxin A4 metabolism by differentiated HL-60 cells and human monocytes: conversion to novel 15-oxo and dihydro products. Biochemistry 1993; 32:6313-6319.